ABCC1, ABCC2 and ABCC3 are implicated in the transepithelial transport of the myco-estrogen zearalenone and its major metabolites

Toxicology Letters

Volumn 190, Issue 2, 2009, Pages 215-223

  Videmann, Bernadette ^a   Mazallon, M ^a   Prouillac, C ^a   Delaforge, Marcel ^b   Lecoeur, Sylvaine ^a  

^a VETAGRO SUP   (France)

^b CEA SACLAY   (France)

Author keywords

ABC transporters; Caco 2 cells; Epithelial cells; Mycotoxin; Zearalenol; Zearalenone

Indexed keywords

ABC TRANSPORTER; ALPHA ZEARALENOL; BETA ZEARALENOL; GLUCURONIDE; MULTIDRUG RESISTANCE PROTEIN 1; MYCOTOXIN; PROTEIN ABCC1; PROTEIN ABCC2; PROTEIN ABCC3; RHODAMINE 123; UNCLASSIFIED DRUG; VERLUKAST; ZEARALENONE;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METABOLITE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIUM; ESTROGENS, NON-STEROIDAL; FLUORESCEINS; HUMANS; KINETICS; LLC-PK1 CELLS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINE 123; RNA, MESSENGER; SWINE; ZEARALENONE;

ANIMALIA;

EID: 69449104493     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.07.021     Document Type: Article

References (58)

1. Anderle P., Niederer E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., Merkle H., and Langguth P. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 87 (1998) 757-762
2. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug. Deliv. 46 (2001) 27-43
3. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B., and Trenholm H.L. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol. Appl. Pharmacol. 121 (1993) 152-159
4. Bony S., Carcelen M., Olivier L., and Devaux A. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay. Toxicol. Lett. 166 (2006) 67-76
5. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
6. Deeley R.G., and Cole S.P.C. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580 (2006) 1103-1111
7. Delie F., and Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limits of the Caco-2 model. Crit. Rev. Ther. Drug 14 (1997) 221-286
8. Essodaigui M., Broxterman H.J., and Garnier-Suillerot A. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37 (1998) 2243-2250
9. Evers R., Zaman G.J.R., van Deemter L., Jansen H., Calafat J., Oomen L.C.J.M., Oude Elferink R.P.J., Borst P., and Schinkel A.H. Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells. J. Clin. Invest. 97 (1996) 1211-1218
10. Evers R., Kool M., van Deemter L., Jansen H., Calafat J., Oomen L.C.J.M., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., and Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 101 (1998) 1310-1319
11. Fink-Gremmels J., and Malekinejad H. Clinical effects and biochemical mechanisms associated with exposure to the mycoestrogen zearalenone. Anim. Feed Sci. Technol. 137 (2007) 326-341
12. Gekeler V., Ise W., Sanders K.H., Ulrich W.R., and Beck J. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208 (1995) 345-352
13. Hipfner D.R., Deeley R.G., and Cole S.P. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461 (1999) 359-376
14. Hirohashi T., Suzuki H., Chu X.Y., Tamai I., Tsuji A., and Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292 (2000) 265-270
15. Hirohashi T., Suzuki H., Takikawa H., and Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J. Biol. Chem. 275 (2000) 2905-3291
16. Hollo Z., Homoloya L., Hegedus T., Muller M., Szakacs G., Jakab K., Antal F., and Sarkadi B. Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1. Anticancer Res. 18 (1998) 2981-2987
17. Huang R., Murry D.J., Kolwankar D., Hall S.D., and Foster D.R. Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochem. Pharmacol. 71 (2006) 1695-1704
18. Keppler D., Cui Y., Kònig J., Leier J., and Nies A. Export pumps for anionic conjugates encoded by MRP genes. Adv. Enzyme Regul. 39 (1999) 237-246
19. Kònig J., Rost D., Cui Y., and Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29 (1999) 1156-1163
20. Kool M., Van der Linden M., De Haas M., Scheffer G.L., De Vree M.L., Smith A.J., Jansan G., Peters G.J., Ponne N., Scheper R.J., Oude Elferink R.P.J., Baas F., and Borst P. MRP3, a new organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Aca. Sci. U.S.A. 96 (1999) 6914-6919
21. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytooestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4423
22. Kuiper-Goodman T., Scott P.M., and Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7 (1987) 253-306
23. Leblanc J., Tard A., Volatier J., and Verger P. Estimated dietary exposure to principal food mycotoxins from the first French Total Diet Study. Food Addit. Contam. 22 (2005) 652-672
24. Lee C.H. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Curr. Med. Chem. Anti-Cancer Agents. 4 (2004) 43-52
25. Leslie E.M., Deeley R.G., and Cole S.P.C. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204 (2005) 216-237
26. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., and Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 30 (2007) 84-94
27. Loe D.W., Stewart R.K., Massey T.E., Deeley R.G., and Cole S.P. ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol. Pharmacol. 6 (1997) 1034-1041
28. Malekinejad H., Maas-Bakker R., and Fink-Gremmels J. Enzyme kinetics of zearalenone biotransformation: pH and cofactor effects. Arch. Toxicol. 79 (2005) 547-553
29. Malekinejad H., Maas-Bakker R., and Fink-Gremmels J. Bioactivation of zearalenone by porcine hepatic biotransformation. Vet. Res. 36 (2005) 799-810
30. Malekinejad H., Van Tol H.T.A., Colenbrander B., and Fink-Gremmels J. Expression of 3α- and 3β-hydroxysteroid dehydrogenase mRNA in COCs and granulose cells determines zearalenone biotransformation. Toxicol. In Vitro 20 (2006) 458-463
31. Meunier V., Bourrie M., Berger Y., and Fabre G. The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 11 (1995) 187-194
32. Nakamura T., Sakaeda T., Ohmoto N., Tamura T., et al. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab. Dispos. 30 (2002) 4-6
33. Olsen M., Pettersson H., and Kiessling K.H. Reduction of zearalenone to zearalenol in female rat liver by 3α-hydroxysteroid dehydrogenase. Acta Pharmacol. Toxicol. (Copenhagen) 48 (1981) 157-161
34. Olsen M., Pettersson H., Sandholm K., Visconti A., and Kiessling K.H. Metabolism of zearalenone by sow intestinal mucosa in vitro. Food Chem. Toxicol. 25 (1987) 681-683
35. Paulusma C.C., Bosma P.J., Zaman G.T., Bakker C.T., Otter M., Scheffer G.L., Scheper R.J., Borst P., and Oude Elferink R.P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271 (1996) 1126-1128
36. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., and Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 47 (1983) 323-330
37. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 9 (2001) e45
38. Prime-Chapman H.M., Fearn R.A., Cooper A.E., Moore A.E., and Hirst B.H. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J. Pharmacol. Exp. Ther. 311 (2004) 476-484
39. Pułaski L., Kania K., Ratajewski M., Uchiumi T., Kuwano M., and Bartosz G. Differential regulation of the human MRP2 andMRP3 gene expression by glucocorticoids. J. Steroid Biochem. Mol. Biol. 96 (2005) 229-234
40. Qian Y.M., Song W.C., Cui H., Cole P.C., and Deeley R.G. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J. Biol. Chem. 9 (2001) 6404-6411
41. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
42. Schinkel A.H., Wagenaar E., Van Deemter L., Mol C.A.A.M., and Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96 (1995) 1698-1705
43. Schrickx J., Lektarau Y., and Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 80 (2006) 243-249
44. Seithel A., Karlsson J., Hilgendorf C., Björquist A., and Ungell A.L. Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur. J. Pharm. Sci. 28 (2006) 291-299
45. Tachampa K., Takeda M., Khamdang S., Noshiro-Kofuji R., Tsuda M., Jariyawat S., Fukutomi T., Sophasan S., Anzai N., and Endou H. Interactions of organic anion transporters and organic cation transporters with mycotoxins. J. Pharmacol. Sci. 106 (2008) 435-443
46. Taipalensuu J., Törnblom H., Lindberg G., Einarsson C., Sjökvist F., Melhus H., Garberg P., Sjöström B., Lundgren B., and Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299 (2001) 164-170
47. Takano M., Yumoto R., and Murakami T. Expression and function of efflux transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
48. Tep J., Videmann B., Mazallon M., Balleydier S., Cavret S., and Lecoeur S. Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters. Toxicol. Lett. 170 (2007) 248-258
49. Vaidyanathan J.B., and Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307 (2003) 745-752
50. Videmann B., Tep J., Cavret S., and Lecoeur S. Epithelial transport of deoxynivalenol: involvement of human p-glycoprotein (ABCB1) and multidrug resistance associated protein 2 (ABCC2). Food Chem. Toxicol. 45 (2007) 1938-1947
51. Videmann B., Mazallon M., Tep J., and Lecoeur S. Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells. Food Chem. Toxicol. 46 (2008) 3279-3286
52. Walle U.K., Galijatovic A., and Walle T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem. Pharmacol. 58 (1999) 431-438
53. Walter E., and Kissel T. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport. Eur. J. Pharm. Sci. 3 (1995) 230
54. Wortelboer H.M., Usta M., van der Velde A.E., Boersma M.G., Spenkelink B., van Zanden J.J., Rietjens I.M.C.M., van Bladeren P.J., and Cnubben N.H.P. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem. Res. Toxicol. 16 (2003) 1642-1651
55. Wortelboer H.M., Usta M., van Zanden J.J., van Bladeren P.J., Rietjens I.M.C.M., and Cnubben N.H.P. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α, β-unsaturated carbonyl compounds. Biochem. Pharmacol. 69 (2005) 1879-1890
56. Yumoto R., Murakami T., Nakamoto Y., Hasegawa R., Nagai J., and Takano M. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther. 289 (1999) 149-155
57. Zaja R., Klobucar R.S., and Smital T. Detection fo Pgp1 (ABCB1) and MRP3 (ABCC3) efflux transporters in the PLHC-1 fish hepatoma cell line. Aquat. Toxicol. 81 (2007) 365-376
58. Zinedine A., Soriano J.M., Molto J.C., and Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 45 (2007) 1-18